1. Home
  2. KN vs BEAM Comparison

KN vs BEAM Comparison

Compare KN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KN
  • BEAM
  • Stock Information
  • Founded
  • KN 1946
  • BEAM 2017
  • Country
  • KN United States
  • BEAM United States
  • Employees
  • KN N/A
  • BEAM N/A
  • Industry
  • KN Consumer Electronics/Appliances
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KN Consumer Staples
  • BEAM Health Care
  • Exchange
  • KN Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • KN 1.8B
  • BEAM 1.6B
  • IPO Year
  • KN N/A
  • BEAM 2020
  • Fundamental
  • Price
  • KN $18.46
  • BEAM $21.16
  • Analyst Decision
  • KN Buy
  • BEAM Strong Buy
  • Analyst Count
  • KN 2
  • BEAM 11
  • Target Price
  • KN $20.50
  • BEAM $48.90
  • AVG Volume (30 Days)
  • KN 571.5K
  • BEAM 2.3M
  • Earning Date
  • KN 07-24-2025
  • BEAM 08-05-2025
  • Dividend Yield
  • KN N/A
  • BEAM N/A
  • EPS Growth
  • KN N/A
  • BEAM N/A
  • EPS
  • KN N/A
  • BEAM N/A
  • Revenue
  • KN $552,400,000.00
  • BEAM $63,578,000.00
  • Revenue This Year
  • KN $6.49
  • BEAM N/A
  • Revenue Next Year
  • KN $5.68
  • BEAM $17.18
  • P/E Ratio
  • KN $67.74
  • BEAM N/A
  • Revenue Growth
  • KN 23.91
  • BEAM N/A
  • 52 Week Low
  • KN $12.19
  • BEAM $13.53
  • 52 Week High
  • KN $20.86
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • KN 63.97
  • BEAM 65.49
  • Support Level
  • KN $17.75
  • BEAM $19.02
  • Resistance Level
  • KN $18.59
  • BEAM $22.51
  • Average True Range (ATR)
  • KN 0.39
  • BEAM 1.15
  • MACD
  • KN 0.03
  • BEAM 0.49
  • Stochastic Oscillator
  • KN 86.13
  • BEAM 78.91

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: